Comparing Bortezomib vs Darzalex
| Bortezomib | Darzalex (daratumumab) |
|
|---|
| Bortezomib | Darzalex (daratumumab) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Multiple Myeloma, Lymphoma, Mantle Cell Lymphoma. Bortezomib may also be used for purposes not listed in this medication guide. |
Prescription only
Darzalex is a CD38 monoclonal antibody that may be used to treat Multiple Myeloma, usually in combination with other treatments. It is given by infusion and upper respiratory tract infections... View more |
Related suggestions Multiple Myeloma
|
|||||||||||||||
| More about Bortezomib | More about Darzalex (daratumumab) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Bortezomib has an average rating of 8.0 out of 10 from a total of 16 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 0% reported a negative effect. |
Darzalex has an average rating of 8.2 out of 10 from a total of 6 ratings on Drugs.com. 83% of reviewers reported a positive effect, while 17% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Bortezomib side effects |
View all Darzalex side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Bortezomib prices |
View all Darzalex prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Boruzu, Velcade |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
15 hours |
432 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 493 drugs are known to interact with Bortezomib:
|
A total of 182 drugs are known to interact with Darzalex:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
May 13, 2003 |
November 16, 2015 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.